<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4369</number>
    <updateDate>2022-12-30T13:34:18Z</updateDate>
    <updateDateIncludingText>2022-12-30T13:34:18Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2021-07-06</introducedDate>
    <congress>117</congress>
    <constitutionalAuthorityStatementText>
      <![CDATA[<pre>[Congressional Record Volume 167, Number 118 (Tuesday, July 6, 2021)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. PALLONE:H.R. 4369.Congress has the power to enact this legislation pursuantto the following:Under Article I, Section 8, Clause 3: [The Congress shallhave Power] To regulate Commerce with foreign Nations, andamong the several States, and with the Indian Tribes.[Page H3611]</pre>]]>
    </constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2021-10-20T15:49:23Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Reported by</name>
                <date>2021-07-15T18:32:50Z</date>
              </item>
              <item>
                <name>Markup by</name>
                <date>2021-07-15T15:42:23Z</date>
              </item>
              <item>
                <name>Referred to</name>
                <date>2021-07-07T18:30:02Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2021-10-19T18:29:02Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2021-07-21T16:08:53Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2021-07-06T16:31:05Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 117-151</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Securing Americaâ€™s Medicine Cabinet Act of 2021</title>
        <congress>117</congress>
        <number>2589</number>
        <type>S</type>
        <latestAction>
          <actionDate>2021-08-03</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2021-10-20</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>19:36:22</actionTime>
        <text>The title of the measure was amended. Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38800</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>19:36:15</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>19:36:14</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318). (text: CR H5645-5647)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>318</rollNumber>
            <url>https://clerk.house.gov/evs/2021/roll318.xml</url>
            <chamber>House</chamber>
            <congress>117</congress>
            <date>2021-10-19T23:36:14Z</date>
            <sessionNumber>1</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>19:36:14</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318).(text: CR H5645-5647)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>318</rollNumber>
            <url>https://clerk.house.gov/evs/2021/roll318.xml</url>
            <chamber>House</chamber>
            <congress>117</congress>
            <date>2021-10-19T23:36:14Z</date>
            <sessionNumber>1</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>19:19:41</actionTime>
        <text>Considered as unfinished business. (consideration: CR H5662-5663)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>16:08:05</actionTime>
        <text>At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.</text>
        <type>Floor</type>
        <actionCode>H37220</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>16:01:19</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4369.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>16:01:18</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H5645-5647)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <actionTime>16:01:03</actionTime>
        <text>Mr. Pallone moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 111.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00111</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2021-10-19</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2021-07-21</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2021-07-21</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2021-07-15</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2021-07-15</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2021-07-07</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2021-07-06</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2021-07-06</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2021-07-06</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000034</bioguideId>
        <fullName>Rep. Pallone, Frank, Jr. [D-NJ-6]</fullName>
        <firstName>FRANK</firstName>
        <lastName>PALLONE</lastName>
        <party>D</party>
        <state>NJ</state>
        <identifiers>
          <bioguideId>P000034</bioguideId>
        </identifiers>
        <district>6</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000558</bioguideId>
        <fullName>Rep. Guthrie, Brett [R-KY-2]</fullName>
        <firstName>Brett</firstName>
        <lastName>Guthrie</lastName>
        <party>R</party>
        <state>KY</state>
        <identifiers>
          <bioguideId>G000558</bioguideId>
        </identifiers>
        <district>2</district>
        <sponsorshipDate>2021-07-06</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2021-10-25T20:27:00Z</pubDate>
        <title>H.R. 4369, National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021</title>
        <url>https://www.cbo.gov/publication/57573</url>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Advanced technology and technological innovations</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Food and Drug Administration (FDA)</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Health programs administration and funding</name>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
        </item>
        <item>
          <name>Higher education</name>
        </item>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>Product development and innovation</name>
        </item>
        <item>
          <name>Research administration and funding</name>
        </item>
        <item>
          <name>Research and development</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2021-07-06</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2021-10-19T16:21:54Z</updateDate>
        <text>
          <![CDATA[ <p><strong>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 </strong></p> <p>This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)</p>]]>
        </text>
      </summary>
      <summary>
        <versionCode>53</versionCode>
        <actionDate>2021-10-19</actionDate>
        <actionDesc>Passed House</actionDesc>
        <updateDate>2021-12-01T11:51:18Z</updateDate>
        <text>
          <![CDATA[ <p><strong>National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 </strong></p> <p>This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)</p>]]>
        </text>
      </summary>
    </summaries>
    <title>National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.</title>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Passed House</titleType>
        <title>National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Official Titles as Amended by House</titleType>
        <title>To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous pharmaceutical manufacturing as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing, and for other purposes.</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <title>National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Referred in Senate</type>
        <date>2021-10-20T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr4369rfs/xml/BILLS-117hr4369rfs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2021-10-19T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr4369rh/xml/BILLS-117hr4369rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2021-10-19T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr4369eh/xml/BILLS-117hr4369eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2021-07-06T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr4369ih/xml/BILLS-117hr4369ih.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date/>
        <formats/>
        <type/>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2021-10-20</actionDate>
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
